Mucoactive drugs in the treatment of bronchitis in children: focus on drugs with ivy extract
Keywords:
bronchitis, children, cough, treatment, ivy leaf extractAbstract
Cough is the most common symptom of bronchitis in children. In the treatment of bronchitis accompanied by coughing, the main task is to relieve cough by improving the rheological properties of bronchial secretions with the aim of their quickest clearance. To achieve this mucolytics, which have the ability to dilute sputum, and mucokinetics (secretomotor), which improve its excretion are used. In pediatrics, preference is given to herbal remedies, which have a milder pharmacotherapeutic effect and better tolerance compared to synthetic drugs. Medicines containing ivy leaf extract (Hederisfolia) are widely used to treat cough in bronchitis. The effectiveness of drugs containing ivy in treating cough has been proven by many trials. Good tolerance allows the widespread use of drugs based on dried ivy extract in pediatric practice.
References
Antypkin JG, Chumachenko NG, Umanets TR, Lapshin VF. (2016). The aspects of respiratory organs pathological conditions dynamics among child population Sovremennaya pediatriya. 2(74): 73–77. https://doi.org/10.15574/SP.2016.74.73
Beketova HV. (2013). Kashel u detei — symptom, trebuiushchyi vnymanyia vracha. Zdorov'ia Ukrainy. Pediatriia.(26): 27.
Bolbot YuK. (2015). Mucolytic Therapy for Respiratory Diseases in Children. Zdorov'e rebenka. 1(60): 98–102.
Hederyn Pliushch. Instruktsiia do zastosuvannia. https://compendium.com.ua/info/171272/gederin/
Korovina NA. (2000). Kashel u detey. Posobie dlya vrachey. Moskva: Posad: 48.
Kruchko TA, Tkachenko OY, Vovk JA. (2014). Treatment of children's cough: from variety of going to inferencing Pedyatryia. Vostochnaia Evropa 3: 131–140.
Marushko YuV, Hracheva MG. (2015). Therapy in bronchopulmonary diseases associated with increased secretion of viscous sputum and impaired mucus ransport. Zdorov’e rebenka.1(60): 135–139. doi: 10.22141/2224-0551.1.60.2015.74978
Marushko YuV, Marushko TV. (2011). Farmakoterapiia zakhvoriuvan orhaniv dykhannia u ditei: Naukovo-informatsiinyi posibnyk. Kyiv: Pryvatna drukarnia FO-P Petryshyn HM: 469.
Marushko YuV, Moskovenko OD. (2015). Sukhyi kashel u ditei: prychyny, osoblyvosti respiratornykh khvorob i likuvannia. Zdorovia dytyny/ 1 (60): 109–114.
Marushko YuV, Shef HH. (2015). Hostryi bronkhit u ditei. Dytiachyi likar. 8(45): 28–36.
Mizernitskiy YuL, Melnikova IM. (2013). Mukoliticheskaya i otharkivayuschaya farmakoterapiya pri zabolevaniyah legkih u detey. Moskva: Medpraktika8M: 120.
Ostrye respiratornye zabolevaniya u detej: lechenie i profilaktika. (2002). Moskva.
Prokhorovа MP. (2015). Differentiated approach to the treatment of cough in children. Immunology and Allergology: Science and Practice.1: 112–118.
Rozinova NN, Sokolova LV, Geppe NA, Sereda EV. (2002). Farmakoterapiya pri bronhitah u detej. Rukovodstvo po farmakoterapii v pediatrii i detskoj hirurgii. Pod red AN Caregorodceva, VA Tabolina. Pulmonologiya. Moskva: 145–154.
Savchenko VP. (2011). Klinichni aspekty i likuvannia kashliu u ditei. Zdorovia Ukrainy. Pediatriia. 18: 54–55.
Selimzyanova LR, Promyslova EA, Vishneva EA. (2013). Cough phytotherapy in children. Pediatric pharmacology. 10;4: 128–130. https://doi.org/10.15690/pf.v10i4.766
Soroka ND, Korshunova EV, Rjabyh OV, Balackaja GM i dr. (2010). Jeffektivnost' i bezopasnost' ingaljacionnogo metoda lechenija suhim jekstraktom list'ev pljushha ostryh respiratornyh zabolevanij u detej rannego vozrasta. Lechashhij vrach. 6: 14–17.
Tumanov VA, Pokanevich VV, Garnik TP, Frolov VM, Peresadin NA. (2012). Phytotherapy: application modern lines in medical practice and perspectives of the further development. Phitoterapiya. 1: 4–11.
Chernikov VV. (2012). Application of vegetable drugs for treating cough in children. Pediatric pharmacology. 9;6: 105–109. https://doi.org/10.15690/pf.v9i6.527
Anti-inflammatory effects of ivy leaves dry extract: influence on transcriptional activity of NFκB (2018). Inflammopharmacology. 27(2). https://doi.org/10.1007/s10787-018-0494-9; PMid:29748881 PMCid:PMC6482290
Diagnosis and management of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 1S8290S.
Dicpinigatis PV, Colice GL, Goolsby MJ et al. (2009). Acute cough: a diagnostic and therapeutic challenge. Cough. 5: 11. https://doi.org/10.1186/1745-9974-5-11; PMid:20015366 PMCid:PMC2802352
Ernst E. (2007). Herbal medicines: balancing benefits and risks. Novartis Found Symp.282: 154–67; discussion 167–72, 212–8. https://doi.org/10.1002/9780470319444.ch11; PMid:17913230
Fazio S, Pouso J, Dolinsky D et al. (2009). Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine.16(1): 17–24. https://doi.org/10.1016/j.phymed.2006.05.003; PMid:16860549
Felix Holzinger and Jean8Franc Ois Chenot. (2011). Systematic Review of Clinical Trials assessing the effectiveness of Ivy Leaf (Hedera Helix) for acute upper respiratory tract infections. Evidence8Based Complementary and Alternative Medicine. 2011. Article ID 382789, 9 p. https://doi.org/10.1155/2011/382789; PMid:20976077 PMCid:PMC2957147
Francesco DB, Johann CV, Mario P et al. (2011). Cough management: a practical approach. Cough. 7: 7. http://www.coughjournal.com/content/7/1/7 https://doi.org/10.1186/1745-9974-7-7; PMid:21985340 PMCid:PMC3205006
Greunke C, Hage-Hulsmann A, Sorkalla T, Keksel N et al. (2015). A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the b2-adrenergic responsiveness of human airway smooth muscle cells. Pulm Pharmacol Ther.31: 92–98. https://doi.org/10.1016/j.pupt.2014.09.002; PMid:25234924
Hocaoglu AB, Karaman O, Erge DO et al. (2012). Effect of Hedera helix on lung histopathology in chronic asthma. Iran J Allergy Asthma Immunol. 11: 316–323.
Hofmann D, Hecker M, Völp A. (2003, Mar). Efficacy of dry extract of ivy leaves in children with bronchial asthma — a review of randomized controlled trials. Phytomedicine.10(2–3): 213–20. https://doi.org/10.1078/094471103321659979; PMid:12725580
Janka Schulte-Michels, Anne Wolf, Stefan Aatz et al. (2016). α-Hederin inhibits G-protein-coupled receptor kinase2-mediated phosphorylation of b2-adrenergic receptors. Phytomedicine.23: 52–57. https://doi.org/10.1016/j.phymed.2015.12.001; PMid:26902407
Marquardt P, Kaft K, Nieber K. (2015). Clinical trials with herbal medicinal products in children: a literature analysis. Wien Med Wochenschr.165(11–12): 236–242. https://doi.org/10.1007/s10354-015-0373-6; PMid:26183729
Schmidt M, Thomsen M, Schmidt U. (2012). Suitability of ivy extract for the treatment of paediatric cough. Phytother Res.26(12): 1942–1947. https://doi.org/10.1002/ptr.4671; PMid:22532491
Sieben A, Prenner L, Sorkalla T, Wolf A et al. (2009). α-Hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behaviour, dynamics and regulation of beta 2-adrenergic receptors. Biochemistry. 48: 3477–3482. https://doi.org/10.1021/bi802036b; PMid:19278262
Suleyman H, Mshvildadze V, Gepdiremen A, Elias R. (2003). Acute and chronic antiinflammatory profile of the ivy plant, Hedera helix, in rats. Phytomedicine 10: 3708374. https://doi.org/10.1078/0944-7113-00260; PMid:12834000
WHO. (2010). WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS). Geneva: WHO8Press: 464.
Downloads
Published
Issue
Section
License
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
